<DOC>
	<DOCNO>NCT01798160</DOCNO>
	<brief_summary>Selective Internal Radiation Therapy superior Transarterial Chemoembolisation treatment intermediate stage hepatocellular carcinoma .</brief_summary>
	<brief_title>Selective Internal Radiation Therapy ( SIRT ) Versus Transarterial Chemoembolisation ( TACE ) Treatment Hepatocellular Carcinoma ( HCC ) .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>≥18 year HCC , proven histology accord EASL criterion Intermediate stage HCC ( stage B accord BCLC ) At least one measurable lesion magnetic resonance imaging ( MRI ) Tumor load ≤ 50 % preserve liver function ( Child Pugh A B ) Patients feasible curative treatment ( e.g . resection local ablation ) Previous TACE SIRT Chemotherapy last 4 week Child Pugh stage C BCLC stage D ECOG Performance Status &gt; 0 Tumor involvement &gt; 50 % liver Extrahepatic tumor Serum Bilirubin &gt; 2.0 mg/dl ; Serum Albumin 2.8 g/dl , Serum Creatinine &gt; 2 mg/dl ; Leukocytes &lt; 3000/ml ; Thrombocytes &lt; 50000/ml Clinically apparent ascites ( ascites CT/MRI exclusion criterion ) Esophageal bleed last 3 month Hepatic encephalopathy Transjugular intrahepatic portosystemic shunt ( TIPS ) Infiltration occlusion portal vein Hepatofugal blood flow portal vein Hepatopulmonary shunt ≥ 20 % macroaggregated albumin scan Contraindications angiography Gravidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>